Synthesis of the seco-Limonoid BCD Ring System Identifies a Hsp90 Chaperon Machinery (p23) Inhibitor

David M. Pinkerton, Sharon Chow, Nada H. Eisa, Kashish Kainth, Timothy J. Vanden Berg, Jed M. Burns, Luke W. Guddat, G. Paul Savage, Ahmed Chadli, Craig M. Williams

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

D-Ring-seco-limonoids (tetranortriterpenoids), such as gedunin and xylogranin B display anti-cancer activity, acting via inhibition of Hsp90 and/or associated chaperon machinery (e.g., p23). Despite this, these natural products have received relatively little attention, both in terms of an enabling synthetic approach (which would allow access to derivatives), and as a consequence their structure–activity relationship (SAR). Disclosed herein is a generally applicable synthetic route to the BCD ring system of the seco-D-ring double bond containing limonoids. Furthermore, cell based assays revealed the first skeletal fragment that exhibited inhibition of the p23 enzyme at a level which was equipotent to that of gedunin, despite being much less structurally complex.

Original languageEnglish (US)
Pages (from-to)1451-1455
Number of pages5
JournalChemistry - A European Journal
Volume25
Issue number6
DOIs
StatePublished - Jan 28 2019

Fingerprint

Limonins
Enzyme inhibition
Machinery
Assays
Enzymes
Display devices
Derivatives
Biological Products
gedunin

Keywords

  • BCD ring
  • Hsp90p23
  • gedunin
  • limonoids
  • medicinal chemistry
  • natural products

ASJC Scopus subject areas

  • Catalysis
  • Chemistry(all)
  • Organic Chemistry

Cite this

Pinkerton, D. M., Chow, S., Eisa, N. H., Kainth, K., Vanden Berg, T. J., Burns, J. M., ... Williams, C. M. (2019). Synthesis of the seco-Limonoid BCD Ring System Identifies a Hsp90 Chaperon Machinery (p23) Inhibitor. Chemistry - A European Journal, 25(6), 1451-1455. https://doi.org/10.1002/chem.201805420

Synthesis of the seco-Limonoid BCD Ring System Identifies a Hsp90 Chaperon Machinery (p23) Inhibitor. / Pinkerton, David M.; Chow, Sharon; Eisa, Nada H.; Kainth, Kashish; Vanden Berg, Timothy J.; Burns, Jed M.; Guddat, Luke W.; Savage, G. Paul; Chadli, Ahmed; Williams, Craig M.

In: Chemistry - A European Journal, Vol. 25, No. 6, 28.01.2019, p. 1451-1455.

Research output: Contribution to journalArticle

Pinkerton, DM, Chow, S, Eisa, NH, Kainth, K, Vanden Berg, TJ, Burns, JM, Guddat, LW, Savage, GP, Chadli, A & Williams, CM 2019, 'Synthesis of the seco-Limonoid BCD Ring System Identifies a Hsp90 Chaperon Machinery (p23) Inhibitor', Chemistry - A European Journal, vol. 25, no. 6, pp. 1451-1455. https://doi.org/10.1002/chem.201805420
Pinkerton, David M. ; Chow, Sharon ; Eisa, Nada H. ; Kainth, Kashish ; Vanden Berg, Timothy J. ; Burns, Jed M. ; Guddat, Luke W. ; Savage, G. Paul ; Chadli, Ahmed ; Williams, Craig M. / Synthesis of the seco-Limonoid BCD Ring System Identifies a Hsp90 Chaperon Machinery (p23) Inhibitor. In: Chemistry - A European Journal. 2019 ; Vol. 25, No. 6. pp. 1451-1455.
@article{bc717a092ab6442583b0271ff54b8688,
title = "Synthesis of the seco-Limonoid BCD Ring System Identifies a Hsp90 Chaperon Machinery (p23) Inhibitor",
abstract = "D-Ring-seco-limonoids (tetranortriterpenoids), such as gedunin and xylogranin B display anti-cancer activity, acting via inhibition of Hsp90 and/or associated chaperon machinery (e.g., p23). Despite this, these natural products have received relatively little attention, both in terms of an enabling synthetic approach (which would allow access to derivatives), and as a consequence their structure–activity relationship (SAR). Disclosed herein is a generally applicable synthetic route to the BCD ring system of the seco-D-ring double bond containing limonoids. Furthermore, cell based assays revealed the first skeletal fragment that exhibited inhibition of the p23 enzyme at a level which was equipotent to that of gedunin, despite being much less structurally complex.",
keywords = "BCD ring, Hsp90p23, gedunin, limonoids, medicinal chemistry, natural products",
author = "Pinkerton, {David M.} and Sharon Chow and Eisa, {Nada H.} and Kashish Kainth and {Vanden Berg}, {Timothy J.} and Burns, {Jed M.} and Guddat, {Luke W.} and Savage, {G. Paul} and Ahmed Chadli and Williams, {Craig M.}",
year = "2019",
month = "1",
day = "28",
doi = "10.1002/chem.201805420",
language = "English (US)",
volume = "25",
pages = "1451--1455",
journal = "Chemistry - A European Journal",
issn = "0947-6539",
publisher = "Wiley-VCH Verlag",
number = "6",

}

TY - JOUR

T1 - Synthesis of the seco-Limonoid BCD Ring System Identifies a Hsp90 Chaperon Machinery (p23) Inhibitor

AU - Pinkerton, David M.

AU - Chow, Sharon

AU - Eisa, Nada H.

AU - Kainth, Kashish

AU - Vanden Berg, Timothy J.

AU - Burns, Jed M.

AU - Guddat, Luke W.

AU - Savage, G. Paul

AU - Chadli, Ahmed

AU - Williams, Craig M.

PY - 2019/1/28

Y1 - 2019/1/28

N2 - D-Ring-seco-limonoids (tetranortriterpenoids), such as gedunin and xylogranin B display anti-cancer activity, acting via inhibition of Hsp90 and/or associated chaperon machinery (e.g., p23). Despite this, these natural products have received relatively little attention, both in terms of an enabling synthetic approach (which would allow access to derivatives), and as a consequence their structure–activity relationship (SAR). Disclosed herein is a generally applicable synthetic route to the BCD ring system of the seco-D-ring double bond containing limonoids. Furthermore, cell based assays revealed the first skeletal fragment that exhibited inhibition of the p23 enzyme at a level which was equipotent to that of gedunin, despite being much less structurally complex.

AB - D-Ring-seco-limonoids (tetranortriterpenoids), such as gedunin and xylogranin B display anti-cancer activity, acting via inhibition of Hsp90 and/or associated chaperon machinery (e.g., p23). Despite this, these natural products have received relatively little attention, both in terms of an enabling synthetic approach (which would allow access to derivatives), and as a consequence their structure–activity relationship (SAR). Disclosed herein is a generally applicable synthetic route to the BCD ring system of the seco-D-ring double bond containing limonoids. Furthermore, cell based assays revealed the first skeletal fragment that exhibited inhibition of the p23 enzyme at a level which was equipotent to that of gedunin, despite being much less structurally complex.

KW - BCD ring

KW - Hsp90p23

KW - gedunin

KW - limonoids

KW - medicinal chemistry

KW - natural products

UR - http://www.scopus.com/inward/record.url?scp=85058946008&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85058946008&partnerID=8YFLogxK

U2 - 10.1002/chem.201805420

DO - 10.1002/chem.201805420

M3 - Article

VL - 25

SP - 1451

EP - 1455

JO - Chemistry - A European Journal

JF - Chemistry - A European Journal

SN - 0947-6539

IS - 6

ER -